Steven L. Hancock, MD; Richard S. Cox, PhD; Saul A. Rosenberg, MD
To the Editors: We have identified an error in data entry that caused us to underestimate the risks for intercurrent death and death from second malignant neoplasms and acute myocardial infarction among survivors of Hodgkin disease (1). The error affected our characterization of survival in the normal population and our subsequent calculations of relative risk. The actuarial survival at 20 years expected for a normal population matched to our Hodgkin disease trial group by age, sex, and race was 91% rather than 67% (revised Figure 2B). The relative risk for death from all causes other than Hodgkin disease in our
Hancock SL, Cox RS, Rosenberg SA. Correction: Deaths after Treatment of Hodgkin Disease. Ann Intern Med. ;114:810. doi: 10.7326/0003-4819-114-9-810
Download citation file:
Published: Ann Intern Med. 1991;114(9):810.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use